Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Karine Valliant-Saunders"'
Limitations of a Transgenic Breast Cancer Model for Studies Erythropoietin-Induced Tumor Progression
Publikováno v:
Translational Oncology. 3:176-180
Adverse effects of erythropoietin (EPO) on tumor progression and survival were observed in recent phase 3 oncology trials. However, mechanisms remain poorly understood. We tested the effects of exogenous EPO on murine B16F10 melanoma growth in a subc
Autor:
Jasmine R. Bryant, Eric J. Watson, Takao Osako, Justine P. Roth, David A. Hrovat, Elizabeth A. Mader, Karine Valliant-Saunders, Ahmad Dehestani, Wai Han Lam, Brian C. Bales, Ernest R. Davidson, Weston Thatcher Borden, Takashi Matsuo, James M. Mayer
Publikováno v:
Journal of Molecular Catalysis A: Chemical. 251:24-33
Many transition metal complexes accomplish or catalyze the oxidation of C H, O H, and other σ-bonds. Under aerobic conditions, metal complexes typically modulate an autoxidation radical chain. In anaerobic reactions, a metal complex can be the react
Publikováno v:
The Journal of Immunology. 196:143.5-143.5
TCR gene therapy hastens the reproducible generation of tumor-specific T cells from patients, creating a promising avenue for treating hematological and solid tumors. Several hurdles remain to making this a broadly effective modality, including varia
Publikováno v:
Digestive diseases and sciences. 57(11)
Forkhead box P3 (FOXP3)+ regulatory T cells (Tregs) are critical for controlling inflammation in the gastrointestinal tract. There is a paradoxical increase of mucosal FOXP3+ T cells in patients with inflammatory bowel disease (IBD). These FOXP3+ cel
Autor:
C. Anthony Blau, Joringel F. Kaiser, Michael Henke, Nicole Urban, Karine Valliant-Saunders, Chris P. Miller, Dominik Mattern, Kimberly A. Lowe
Publikováno v:
Stem cells (Dayton, Ohio). 27(9)
Despite the prevalence of anemia in cancer, recombinant erythropoietin (Epo) has declined in use because of recent Phase III trials showing more rapid cancer progression and reduced survival in subjects randomized to Epo. Since Epo receptor (EpoR), J
Autor:
Erica Gunn, David A. Hrovat, Karine Valliant-Saunders, G. Robert Shelton, James M. Mayer, Weston Thatcher Borden
Publikováno v:
Inorganic chemistry. 46(13)
In the presence of an excess of pyridine ligand L, osmium tetroxide oxidizes tertiary silanes (Et(3)SiH, (i)Pr(3)SiH, Ph(3)SiH, or PhMe(2)SiH) to the corresponding silanols. With L = 4-tert-butylpyridine ((t)Bupy), OsO(4)((t)Bupy) oxidizes Et(3)SiH a
Autor:
James M. Mayer, Elizabeth A. Mader, Justine P. Roth, Jasmine R. Bryant, Takashi Matsuo, Ahmad Dehestani, Brian C. Bales, Eric J. Watson, Takao Osako, Karine Valliant-Saunders, et al. et al.
Publikováno v:
ChemInform. 38
Publikováno v:
Inflammatory Bowel Diseases. 17:S83
Publikováno v:
Clinical Immunology. 135:S35
Autor:
Richard C. Thirlby, James D. Lord, Steven F. Ziegler, Robert C. Hackman, Karine Valliant-Saunders, Amanda Moklebust
Publikováno v:
Clinical Immunology. 127:S118